Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2026-03-01 @ 1:49 AM
Study NCT ID:
NCT05419869
Status:
COMPLETED
Last Update Posted:
2024-01-18
First Post:
2022-05-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Decentralized Trial
Sponsor:
Alto Neuroscience
Organization:
Study Overview
Official Title:
An Open-Label Study of ALTO-100 in Adults With Major Depressive Disorder (MDD)
Status:
COMPLETED
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to collect biologically-based data for defining predictors and correlates of the effects of ALTO-100.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: